Noom GLP-1 vs GlucoPal: Program or Tracker? (2026)

Noom has been in weight loss for more than a decade, and it now runs a telehealth program that connects you to licensed clinicians, prescribes GLP-1 medication, and ships it to your door if prescribed. In June 2026 it also launched a free GLP-1 Companion app experience for anyone taking a GLP-1. The question is not whether Noom is legitimate. It is whether a care program and a journey tracker are the same product, because they are not.

Quick answer: Choose GlucoPal if you already have a prescription, from any provider, and what you need is the daily record: dose history with automatic injection-site rotation, side effects tied to your dose timeline, meals and protein, weight trends, progress photos, an estimated medication-level chart, and a doctor-ready PDF export you can hand to any clinician. Choose Noom if you do not have a prescription yet, or you want clinician access, dose management, insurance and prior-authorization help, and a structured behavioral curriculum in one program. Many people use both: Noom for the prescription and the clinical care, GlucoPal for the record.

Every Noom detail below was checked against Noom's own pages and its US App Store listing on August 25, 2026. Programs and app listings change often, so re-check current pricing and features before you sign up for anything.

What is Noom's GLP-1 program?

Noom Med is telehealth. Its own page describes "100% online access to licensed clinicians," "weight-loss medication shipped to your door, if prescribed," "personalized dosing to minimize side effects," and "unlimited access to your clinician and medication refills, where clinically appropriate." It adds supportive coaches, community, and a Muscle Defense program aimed at preserving muscle during weight loss. The page states you do not need insurance to access Noom Med medications.

The medications named on that page include Wegovy, Wegovy Pill, Ozempic, Zepbound, Mounjaro, and generic liraglutide, alongside Noom's own compounded options (Noom Microdose GLP-1Rx and Noom GLP-1Rx Plus), plus metformin and Foundayo.

One part of the program is easy to underrate. Noom's support documentation says Care Coordinators "are available in the Noom app, manage the prior authorization process for you and keep you updated about next steps," and it publishes the timelines plainly: prior-authorization decisions may take up to 14 days, appeals up to 90 days. If an appeal is denied or delayed, coordinators can connect you with a clinician to discuss alternatives. If you have ever fought an insurer alone, that is real work being done on your behalf. Noom also publishes a free GLP-1 insurance checker.

Then there is the app side. Noom's GLP-1 Companion, which the company announced as a free version on June 24, 2026 and described as available to anyone taking a GLP-1 medication regardless of provider, covers more ground than people assume. Its pages describe "intelligent med tracking and dosing" with medication reminders, side-effect guides in a Success Kit, individualized protein and macro targets, easy photo-based meal logging, weight tracking, body composition scans for lean mass versus body fat, Muscle Defense workouts through a FitOn partnership, daily psychology lessons, Circles communities, and Seeds rewards. Its App Store listing describes syncing with Apple Health, Fitbit, Garmin, and Withings.

So dose logging, reminders, AI photo meal logging, protein targets, and weight tracking are all there. Food logging has been Noom's strength since long before GLP-1s existed. If you read a comparison claiming Noom cannot log meals or protein, that comparison is out of date.

What does the Companion leave out?

The most decision-relevant gap is the one you notice at an appointment. A doctor-ready PDF export is not described on Noom's GLP-1 Companion page, its Noom Med page, the free-version announcement, or its US App Store listing as of August 25, 2026. That matters because a Noom member still sees clinicians outside Noom: a primary care doctor, whoever orders labs, a specialist, or the next prescriber if the program ends. An organized export answers "how has it been going?" in one page, in any exam room, without handing over your phone.

Three more items are not described on those same sources as of August 25, 2026:

• Injection-site rotation with a body map. Manufacturer instructions tell patients to rotate sites with each dose, and a map beats memory once you are twenty weeks in. See our guide to injection-site rotation for why the pattern matters.
• Progress photos. Noom describes body composition scans that estimate lean mass versus body fat. That is a different feature with a different purpose, and it is worth not confusing the two. Scans measure composition; photos show change your scale misses during a plateau.
• An estimated medication-level chart. Noom describes "personalized dosing" as a clinical approach handled by its clinicians, not a user-facing chart of estimated drug levels between doses.

Side effects are the partial case. Noom describes side-effect guides and clinician support, which is genuinely useful when nausea hits. What is not described is logging symptoms against your own dose timeline, so you can see whether week one after a titration step is consistently rougher than week three. Our posts on side-effect tracking and GLP-1 nausea cover what that pattern usually looks like.

The privacy labels also describe different postures. Noom, Inc.'s US App Store label indicates data used to track you (including purchases, financial info, location, user content, identifiers, and sensitive info) and data linked to you spanning health and fitness, contact info, photos or videos, usage data, diagnostics, and environment scanning, with listed purposes including analytics and product personalization. GlucoPal requires no account to start and does not sell your health information. Neither label is a scandal, but they are not the same posture, and the FTC's guidance on health apps is worth applying to both before you download either.

Noom GLP-1 vs GlucoPal side by side

Feature summary: Both track doses, send reminders, log meals by photo, set protein targets, chart weight, and sync with Apple Health. Noom adds what a tracker cannot: clinicians who prescribe, medication shipped if prescribed, Care Coordinators who run prior authorization, coaching, and a behavior-change curriculum. GlucoPal adds what a program page does not describe: injection-site rotation with a body map, side effects on the dose timeline, progress photos, an estimated medication-level chart, a doctor-ready PDF export, and coverage of any GLP-1 regardless of who prescribed it.

Two pricing notes worth reading twice. Noom's pricing page states that insurance does not cover the Noom program itself, though branded medication may be covered separately, and that the medication cost is not included in the branded-medication plan. Separately, Noom's US App Store listing lists in-app purchases ranging from $9.99 to $199.99 per item, including a Noom Pro item and multiple Noom Program items (checked August 25, 2026). Treat every figure here as a starting point and confirm current numbers on Noom's pricing page before you enroll.

When Noom is the right choice

If you do not have a prescription yet, a tracker cannot help you get one. Noom Med can. That is the clean case: you want a clinician, you want the medication shipped if it is prescribed, and you would rather not assemble a prescriber, a pharmacy, and an insurance appeal on your own.

It is also the pick if insurance is the hard part of your situation. Published timelines and a Care Coordinator who files the prior authorization for you are worth something specific when a decision can take up to 14 days and an appeal up to 90.

And it is the pick if you want structure around the medication rather than only a record of it. Noom's curriculum, coaching, and communities have a long track record, and Muscle Defense programming with body composition scans speaks to a real concern about lean mass during rapid weight loss. If you are uninsured, Noom's page states insurance is not required to access its medications, including its compounded microdose options.

Why people add a journey tracker anyway

A GLP-1 prescription produces more record than a dose date and a weight. Appetite drops and protein gets hard to hit, which is why our guide to protein goals on a GLP-1 exists and why muscle preservation shows up in every serious program. Sites need rotating. Symptoms mean more when you can see them against dose timing. Photos catch what the scale hides. And at the appointment, an organized export beats scrolling through screens.

GlucoPal is built around that whole record: 4.8 stars, 100,000+ users, free to download and use with optional Pro at $9.99/mo or $29.99/yr, and no account required to start. Doses with automatic site rotation, meals by photo or search, side effects on the timeline, weight trends, progress photos, an estimated medication-level chart, Apple Health sync, and a doctor-ready PDF export, in one place. It covers oral GLP-1s too, which matters as more people move to pills; see our Wegovy pill tracker guide.

Nothing about the two conflicts. Get the prescription and the clinical care through a program like Noom, keep the day-to-day record in GlucoPal, and take the export to whichever clinician you see next. The same logic applies to manufacturer apps, which we cover in Lilly Health vs GlucoPal, and to the wider field in our free GLP-1 tracker app roundup.

Neither a program nor a tracker replaces clinical judgment. Dosing changes, missed doses, and severe symptoms belong with your clinician or pharmacist.

FAQ

Is Noom legit for GLP-1?

Yes. Noom Med is a telehealth program with licensed clinicians who prescribe and manage GLP-1 medications, with medication shipped if prescribed, per noom.com/med (checked August 25, 2026). The thing to understand before signing up is the category: it is a care program with a companion app, not a standalone tracker you install and own.

How much does Noom GLP-1 cost?

Noom publishes starting prices by program on its pricing page. As of August 25, 2026, telehealth for branded medication starts at $39 per that page, with the page stating the cost of medication is not included, and it also states that insurance does not cover the Noom program itself. Check Noom's pricing page for current figures, since program pricing changes. GlucoPal is free to download and use, with optional GlucoPal Pro at $9.99/mo or $29.99/yr.

Does Noom have a GLP-1 tracking app?

Yes. Noom's GLP-1 Companion is described as including med tracking and dosing with reminders, photo-based meal logging, individualized protein and macro targets, weight tracking, body composition scans, side-effect guides, workouts, and daily lessons, and Noom announced a free version on June 24, 2026 for anyone taking a GLP-1 regardless of provider. Not described on those pages as of August 25, 2026: injection-site rotation with a body map, progress photos, an estimated medication-level chart, or a doctor-ready PDF export.

Does Noom track injection sites?

Injection-site rotation with a body map is not described on Noom's GLP-1 Companion page, its Noom Med page, or its US App Store listing as of August 25, 2026. If you want the site history handled for you, that is what GlucoPal's automatic rotation and body map do. Our injection-site rotation guide explains why the pattern is worth keeping.

Can I use Noom and GlucoPal together?

Yes, and it is the setup that makes the most sense for a lot of people. Noom handles the prescription, the clinician, the prior authorization, and the curriculum. GlucoPal handles the record: dose history, injection sites, side effects on the timeline, meals and protein, weight, photos, and the doctor-ready export you can bring to any clinician, including one outside the program.

Sources

1. 01.Noom Med - program inclusions (online clinician access, medication shipped if prescribed, personalized dosing, refills, coaching and community, Muscle Defense), medications named, and the statement that insurance is not required to access Noom Med medications (checked August 25, 2026)
2. 02.Noom Med pricing - published starting prices by program, the statement that medication cost is not included on the branded-medication plan, and the statement that insurance does not cover the Noom program itself (checked August 25, 2026)
3. 03.Noom support - branded medication availability, prior authorization and appeals - Care Coordinators managing prior authorization, the up-to-14-day decision and up-to-90-day appeal timelines, and alternative-medication support (checked August 25, 2026)
4. 04.Noom GLP-1 Companion - described Companion features including med tracking and dosing, reminders, side-effect guides, protein and macro targets, photo meal logging, weight tracking, body composition scans, and workouts (checked August 25, 2026)
5. 05.Noom announcement - free version of the GLP-1 Companion - June 24, 2026 announcement that the Companion is available at no cost to anyone taking a GLP-1 medication regardless of provider (checked August 25, 2026)
6. 06.App Store - Noom: Weight Loss, Food Tracker - 4.7 average from about 870,700 US ratings, device syncing (Apple Health, Fitbit, Garmin, Withings), in-app purchase range of $9.99 to $199.99 per item, and privacy label details (checked August 25, 2026)
7. 07.App Store - GLP-1 Tracker by GlucoPal - 4.8 average from about 2,700 US ratings, supported medications including oral and compounded GLP-1s, injection-site rotation, AI meal scanning, side effects, progress photos, medication-level chart, doctor-ready export, and no-account and no-selling statements (checked August 25, 2026)
8. 08.GlucoPal official website - product positioning, 100,000+ users, and GlucoPal Pro pricing
9. 09.FTC Consumer Advice - Does your health app protect your sensitive info? - consumer guidance on reviewing health app privacy and data-use practices before download